Detalhe da pesquisa
1.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-up From a Phase 3 Trial.
J Urol
; : 101097JU0000000000004020, 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704840
2.
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Lancet Oncol
; 22(1): 107-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253641
3.
Microhematuria: AUA/SUFU Guideline.
J Urol
; 204(4): 778-786, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698717
4.
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(3): 329-354, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135513
5.
Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach.
BMC Health Serv Res
; 20(1): 686, 2020 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32709234
6.
American Urological Association Nonmuscle Invasive Bladder Cancer Risk Model Validation-Should Patient Age be Added to the Risk Model?
J Urol
; 202(4): 682-688, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31188732
7.
The Impact of Agent Orange Exposure on Prostate Cancer Outcomes.
J Urol
; 201(4): 742-750, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30321553
8.
Impact of bilateral biopsy-detected prostate cancer on an active surveillance population.
BMC Urol
; 19(1): 26, 2019 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31014300
9.
Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy.
J Urol
; 200(6): 1256-1263, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29940252
10.
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
J Natl Compr Canc Netw
; 16(9): 1041-1053, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181416
11.
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in a United States Population.
J Urol
; 198(4): 824-831, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28433642
12.
Tolerability of Repeat Use of Blue Light Cystoscopy with Hexaminolevulinate for Patients with Urothelial Cell Carcinoma.
J Urol
; 197(3 Pt 1): 596-601, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27664580
13.
Emerging Impact of Malnutrition on Surgical Patients: Literature Review and Potential Implications for Cystectomy in Bladder Cancer.
J Urol
; 198(3): 511-519, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28286066
14.
Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2 ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression.
BJU Int
; 120(3): 387-393, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28464520
15.
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(10): 1240-1267, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28982750
16.
Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies.
Curr Urol Rep
; 18(7): 48, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28589399
17.
Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer.
BJU Int
; 118(3): 399-407, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26589741
18.
Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer.
J Urol
; 194(5): 1214-9, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26173101
19.
Multi-Quadrant Biopsy Technique Improves Diagnostic Ability in Large Heterogeneous Renal Masses.
J Urol
; 194(4): 886-91, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25837535
20.
The Future State of Race/Ethnicity in Urology: Urology Workforce Projection From 2021-2061.
Urology
; 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354914